Congress Materials – Genitourinary Cancers Symposium (GU-2025)
2025 Genitourinary Cancers Symposium | Feb 13-15 | San Francisco, CA
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
Association Of PSMA PET Results At Biochemical Recurrence With Metastasis Free Survival By Conventional Imaging In Patients With In Locally Advanced Or High-Risk Localized Prostate Cancer Initially Treated With Radical Prostatectomy: A Retrospective Multicenter Study
Jesus Juarez Casillas, Thomas Hope, Jeremie Calais, Wolfgang Fendler, Matthias Eiber, Fei Jiang, Abuzar Moradi Tuchayi, Ken Herrmann, Vishnu Murthy, Luisa Willner, Andrew Nguyen, Madeleine Karpinski, Lela Theus, Türkay Hekimsoy, Alexander Kretschmer, Sharon McCarthy, Branko Miladinovic, Megan Price, Ariel Bourla, Jose Zamalloa
Biomarker Testing Patterns Among Patients Newly Diagnosed With Prostate Cancer In a Community Oncology Network
Lisa Dwyer Orr, Siraje Mahmud, Mika Cline, Ayda Mirsalehi, Monica Lisi, Laura Ensley, Lorraine Brisbin, Roy Paulson
Deep Prostate-Specific Antigen Decline Among Early Participants In LIBERTAS, a Phase 3 Study Of Apalutamide Plus Continuous Versus Intermittent Androgen Deprivation Therapy In Metastatic Castration-Sensitive Prostate Cancer
Arun Azad, Marco Antonio Badillo, Qiang Dong, Alicia K. Morgans, Dana E. Rathkopf, Karie Runcie, Tian Zhang, Geoffrey Gotto, Axel S. Merseburger, Alex Dos Santos, Sukie Shopeju, Amitabha Bhaumik, Suneel D. Mundle, Sharon A. McCarthy, Neeraj Agarwal
Efficacy And Safety Of Apalutamide In Metastatic Castration Sensitive Prostate Cancer Patients With a Prior History Of Cardiovascular Or Metabolic Risk Factors – A Post-Hoc Analysis Of The TITAN Study
Arun Azad, Ding-Wei Ye, Hiroji Uemura, Amitabha Bhaumik, Michael Eisbacher, Anildeep Singh, Sharon McCarthy, Suneel Mundle, Kim N. Chi, Neeraj Agarwal
Estimation Of Overall Survival In Immunotherapy-Treated Bladder Cancer Using Computer Vision
Brandon Ginley, Bolan Linghu, Chaitanya Parmar, Neil Beeharry, Shibu Thomas, Patricia Raciti, Joel Greshock, Kristopher Standish, Albert Juan Ramon
Management Strategies And Patient Outcomes Among Localized Prostate Cancer Patients With Persistently Positive PSA After Radical Prostatectomy
Shawn Malone, Christopher Wallis, Ilias Cagiannos, Robert Hamilton, Naveen Basappa, Cristiano Ferrario, Geoffrey Gotto, Ricardo Fernandes, Tamim Niazi, Christopher Morash, Ricardo Rendon, Fred Saad, Sebastien Hotte, Brendan Osborne, Katherine Chan, Anousheh Zardan, Bobby Shayegan
Population-Based Assessment Of Treatment Patterns For High-Risk Localized Prostate Cancer
Christopher J.D. Wallis, Shawn Malone, Ilias Cagiannos, Robert Hamilton, Naveen Basappa, Cristiano Ferrario, Geoffrey Gotto, Ricardo Fernandes, Tamim Niazi, Christopher Morash, Ricardo Rendon, Fred Saad, Sebastien Hotte, Brendan Osborne, Anousheh Zardan, Bobby Shayegan
Prostate-Specific Antigen Response In Black Patients With Metastatic Castration-Sensitive Prostate Cancer Treated With Apalutamide Versus Abiraterone Acetate – A Real-World Comparison
Gordon Brown, Shawn Du, Ibrahim Khilfeh, Carmine Rossi, Sabree Burbage, Frederic Kinkead, Lilian Diaz, Dominic Pilon, Benjamin Lowentritt
Radiographic Progression Without PSA Progression (R-PD) In Advanced Prostate Cancer Patients
Ruchi Chaudhary, Amitabha Bhaumik, Neeraj Agarwal, Kristin Shotts, Angela Lopez-Gitlitz, Sharon McCarthy, Suneel Dinkar Mundle, Kim Chi, Eric Small
Real World Comparison Of Time-To-Next-Treatment, Time-To-Castration-Resistance, And Overall Survival Among Patients With BRCA1/2 Positive And Homologous Recombination Repair Negative Metastatic Castration-Sensitive Prostate Cancer
Heather H. Cheng, Sabree Burbage, Carmine Rossi, Ibrahim Khilfeh, Lilian Diaz, Yuxi Wang, Dominic Pilon, Gordon Brown, Neal Shore, Benjamin Lowentritt, Daniel W. Lin, Mehmet Bilen
Time Burden And Healthcare Costs Associated With Docetaxel In Patients With Metastatic Castration-Sensitive Prostate Cancer Initiating An Androgen Receptor Pathway Inhibitor-Based Regimen
Daniel Sentana Lledo, Arjun Gupta, Carmine Rossi, Sabree Burbage, Lilian Diaz, Gordon Wong, Dominic Pilon, Ibrahim Khilfeh, Alicia Morgans
Treatment Patterns And Clinical Outcomes In Patients With Metastatic Urothelial Carcinoma (mUC) In England: A Retrospective Observational Study
Tinevimbo Shiri, Max Nievaart, Will Perkin, Simran Gill
Copies of these presentation are for personal use only and may not be reproduced without permission from ASCO® or the author of this presentation.